Preoperative and postoperative haemoglobin and haematocrit values, intraoperative blood loss, and any blood product transfusion were recorded.Results: Blood loss during SARPE was statistically significantly less in the study group than the control group (p=0.0001).Conclusion: Preoperative IV administration of TXA can effectively control blood loss during when SARPE with pterygoid disjunction is performed.
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Purpose: The purpose of this study was to evaluate the efficacy of tranexamic acid (TXA) in reducing blood loss during surgically assisted rapid palatal expansion (SARPE) procedure.Subjects and Methods: A total of 34 patients (12 male, 22 female) who had been treated surgically under general anesthesia with SARPE including pterygoid disjunction for transverse maxillary deficiency (TMD) were included in this study.
📊
Temel Bulgular & Veri:The study group (n=17) received intravenous (IV) TXA 10 mg/kg as a preoperative bolus; the control group (n=17) received normal saline solution.
💡
Sonuç & Katkı:Preoperative and postoperative haemoglobin and haematocrit values, intraoperative blood loss, and any blood product transfusion were recorded.Results: Blood loss during SARPE was statistically significantly less in the study group than the control group (p=0.0001).Conclusion: Preoperative IV administration of TXA can effectively control blood loss during when SARPE with pterygoid disjunction is performed.
Purpose: The purpose of this study was to evaluate the efficacy of tranexamic acid (TXA) in reducing blood loss during surgically assisted rapid palatal expansion (SARPE) procedure.Subjects and Methods: A total of 34 patients (12 male, 22 female) who had been treated surgically under general anesthesia with SARPE including pterygoid disjunction for transverse maxillary deficiency (TMD) were included in this study. The study group (n=17) received intravenous (IV) TXA 10 mg/kg as a preoperative bolus; the control group (n=17) received normal saline solution. Preoperative and postoperative haemoglobin and haematocrit values, intraoperative blood loss, and any blood product transfusion were recorded.Results: Blood loss during SARPE was statistically significantly less in the study group than the control group (p=0.0001).Conclusion: Preoperative IV administration of TXA can effectively control blood loss during when SARPE with pterygoid disjunction is performed.
AKBAŞ, E., CANSIZ, E., İŞLER, S. C., ÇAKARER, S., ÇEBİ, Z. (2017). DOES INTRAVENOUS TRANEXAMIC ACID REDUCE BLOOD LOSS DURING SURGICALLY ASSISTED RAPID PALATAL EXPANSION?. European Oral Research, Cilt: 51 - Sayı: 3, 32–37. https://ajindex.com/articles/242980
Handelman CS. Nonsurgical rapid maxillary alveolar expansion in adults: A clinical evaluation. Angle Orthod 1997;67(4):291-305; discussion 306-298.
Verlinden CR, Gooris PG, Becking AG. Complications in transpalatal distraction osteogenesis: A retrospective clinical study. J Oral Maxillofac Surg 2011;69(3):899-905.
Babacan H, Sokucu O, Doruk C, Ay S. Rapid maxillary expansion and surgically assisted rapid maxillary expansion effects on nasal volume. Angle Orthod 2006;76(1):66-71.
Greenbaum KR, Zachrisson BU. The effect of palatal expansion therapy on the periodontal supporting tissues. Am J Orthod 1982;81(1):12-21. Haas AJ. Long-term posttreatment evaluation of rapid palatal expansion. Angle Orthod 1980;50(3):189-217.
Langford SR, Sims MR. Root surface resorption, repair, and periodontal attachment following rapid maxillary expansion in man. Am J Orthod 1982;81(2):108-115.
Lanigan DT, Mintz SM. Complications of surgically assisted rapid palatal expansion: Review of the literature and report of a case. J Oral Maxillofac Surg 2002;60(1):104-110. Mommaerts MY. Transpalatal distraction as a method of maxillary expansion. Br J Oral Maxillofac Surg 1999;37(4):268-272.
Song G, Yang P, Hu J, Zhu S, Li Y, Wang Q. The effect of tranexamic acid on blood loss in orthognathic surgery: A meta-analysis of randomized controlled trials. Oral Surg Oral Med Oral Pathol Oral Radiol 2013;115(5):595-600. Timms DJ. A study of basal movement with rapid maxillary expansion. Am J Orthod 1980;77(5):500-507.
Hynes M, Calder P, Scott G. The use of tranexamic acid to reduce blood loss during total knee arthroplasty. Knee 2003;10(4):375-377.
Ho KM, Ismail H. Use of intravenous tranexamic acid to reduce allogeneic blood transfusion in total hip and knee arthroplasty: A meta-analysis. Anaesth Intensive Care 2003;31(5):529-537. Neilipovitz DT. Tranexamic acid for major spinal surgery. Eur Spine J 2004;13 Suppl 1:S62-65. Laupacis A, Fergusson D. Drugs to minimize perioperative blood loss in cardiac surgery: Meta-analyses using perioperative blood transfusion as the outcome. The international study of peri-operative transfusion (ISPOT) investigators. Anesth Analg 1997;85(6):1258-1267.
Dunn CJ, Goa KL. Tranexamic acid: A review of its use in surgery and other indications. Drugs 1999;57(6):1005-1032.
Patatanian E, Fugate SE. Hemostatic mouthwashes in anticoagulated patients undergoing dental extraction. Ann Pharmacother 2006;40(12):2205-2210.
Sethna NF, Zurakowski D, Brustowicz RM, Bacsik J, Su